Remove Bottom-up Remove Finance Remove Marketing Remove Pharmaceuticals
article thumbnail

What’s Driving Superstar Companies, Industries, and Cities

Harvard Business Review

These firms make up two thirds of global corporate pretax earnings (EBTDA) and revenues. We focus on economic profit rather than revenue size, market share, or productivity growth because these other metrics risk including firms that are simply large and may not create economic value. Superstar firms create 1.6

article thumbnail

Gloominess About the US Economy is a Choice

Harvard Business Review

As collectibles go, magazines are at the bottom of the list. But an awful lot of these jobs command very high-wages in law, finance, accounting, consulting, advertising, engineering, design, software, healthcare, scientific research, architecture, entertainment, hospitality, and many other areas. I just don’t buy it. eat our lunch.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Business Needs to Do What Government Can't

Harvard Business Review

Just under 1,000 companies account for half of the world's market capitalization, Eccles notes. Breakthrough requires an end to systemic inequities by opening up processes, information - and markets. Perhaps surprisingly, two leading examples come from pharmaceutical companies. Breakthrough Finance.

EPS 8
article thumbnail

What a Changing NAFTA Could Mean for Doing Business in Mexico

Harvard Business Review

The possibility of a contentious renegotiation of the North American Free Trade Agreement (NAFTA) has led to delayed or canceled investments in what has been one of Latin America’s most economically stable markets. The bottom line is, multinationals will not know what will be in the final agreement for years. Renegotiating NAFTA.